AKT1 and asthma: Particularly, based on literature research reports [18–20] and the KEGG results, the potential mechanism of YPF in treating asthma was mainly focused on the TNF signaling pathway, PI3K-Akt signaling pathway, IL-17 signaling pathway, and Th17 cell differentiation (Table 1).